Many of the best multi-baggers such as EUA, ARB and GGP started off with the same gaps through resistance as the technical buy signal.

Many of the best multi-baggers such as EUA, ARB and GGP started off with the same gaps through resistance as the technical buy signal.
Zak Mir highlights some of the most followed stocks on the small-cap and gives an overview in this video charting update on why they joined that special group of “Multibaggers”
License to utilise Avacta’s pre|CISIONTM FAP sensitive activation platform for radiopharmaceuticals
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISIONTM platforms, is pleased to announce significant progress in the development
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Zak Mir highlights some of the most followed pharmaceutical stocks on the small-cap London market and gives an overview in this video charting update.
Zak Mir highlights some of the most followed pharmaceutical stocks on the small-cap London market and gives an overview in this video charting update.
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Avacta released its unaudited interim results for the six-month period ended 30 June 2020 on Monday. They detailed a period of significant advancement for the Group despite the restrictions placed upon it
Affimer-based research assay launched alongside performance data published by Bruker